CVS Health Corp. buy TD Cowen
Summary
This prediction ended on 12.12.24 with a price of €49.29. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.21%. TD_Cowen has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €2.46 are taken into consideration when calculating the performance. TD_Cowen has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -3.800% | -3.800% | 32.439% |
| iShares Core DAX® | -0.710% | -1.054% | 24.950% |
| iShares Nasdaq 100 | 1.556% | 6.792% | 22.201% |
| iShares Nikkei 225® | 4.150% | 11.126% | 27.240% |
| iShares S&P 500 | 0.738% | 4.015% | 13.707% |
Comments by TD_Cowen for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.